Glamorous AI

London, United Kingdom Founded: 2020 • Age: 6 yrs Acquired By X-Chem
Preclinical studies for biopharma drug discovery are conducted.
Request Access

About Glamorous AI

Glamorous AI is a company based in London (United Kingdom) founded in 2020 was acquired by X-Chem in October 2021.. Glamorous AI offers products and services including DEL Screening, ReadiDEL, ReadiBLOX, ArtemisAI, and HITMiner. Glamorous AI operates in a competitive market with competitors including GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others.

  • Headquarter London, United Kingdom
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    X-Chem

    (Oct 28, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Glamorous AI

Glamorous AI offers a comprehensive portfolio of products and services, including DEL Screening, ReadiDEL, ReadiBLOX, ArtemisAI, and HITMiner. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Screening platform for identifying small molecule hits using DNA libraries.

Pre-built library for rapid drug discovery applications.

Modular blocks for custom medicinal chemistry synthesis.

AI tool for analyzing molecular interactions in drug discovery.

Platform for mapping compounds and expanding hits in research.

Funding Insights of Glamorous AI

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Glamorous AI

Glamorous AI has secured backing from 1 investor. Prominent investors backing the company include X-Chem. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Small molecule drug discovery platform is provided to researchers.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Glamorous AI

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Glamorous AI

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Glamorous Ai Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Glamorous AI

Glamorous AI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of transgenic rodent models and customized cell lines for preclinical development
domain founded_year HQ Location
Humanized mouse models are developed for preclinical immune drug studies.
domain founded_year HQ Location
Animal models are supplied for in-vivo analytical services.
domain founded_year HQ Location
Preclinical CRO services for CNS and orphan disorders are offered.
domain founded_year HQ Location
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
domain founded_year HQ Location
Preclinical contract research organization offering standard GLP and non-GLP services
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Glamorous Ai

Frequently Asked Questions about Glamorous AI

When was Glamorous AI founded?

Glamorous AI was founded in 2020.

Where is Glamorous AI located?

Glamorous AI is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

What does Glamorous AI do?

Glamorous AI was founded in 2020 and is based in London, United Kingdom. Operations focus on the biopharma sector, where preclinical studies are conducted to support drug discovery processes. Services include analysis and testing in early-stage research, aiding pharmaceutical companies in development pipelines. The company maintains a domain at glamorous.ai for its digital presence.

Who are the top competitors of Glamorous AI?

Glamorous AI's top competitors include GenOway, PsychoGenics and PharmaLegacy Laboratories.

What products or services does Glamorous AI offer?

Glamorous AI offers DEL Screening, ReadiDEL, ReadiBLOX, ArtemisAI, and HITMiner.

Who are Glamorous AI's investors?

Glamorous AI has 1 investor. Key investors include X-Chem.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available